Concomitant Chemo-radiotherapy and Local Dose of Radiation As Risk Factors for Second Malignant Neoplasms After Solid Cancer in Childhood: a Case-control Study.
From: National Institute of Public Health and Medical Research (INSERM), Unit 605, Villejuif, France. guerin@igr.fr
International journal of cancer. Journal international du cancer
- Publish Date: Jan 2007
- ISSN: 0020-7136
- Volume: 120
- Issue: 1
- Pages: 96-102
- Medium: Print
- Language: English
- Citation (JAMA): Guérin Sylvie, Guibout Catherine, Shamsaldin Akthar, et al. Concomitant Chemo-radiotherapy and Local Dose of Radiation As Risk Factors for Second Malignant Neoplasms After Solid Cancer in Childhood: a Case-control Study.. Int. J. Cancer Jan 2007;120:96-102
Abstract
Radiotherapy and chemotherapy are associated with an increased risk of a second malignant neoplasm (SMN) after a cancer during childhood. This study specified the dose-effect relationship between radiotherapy, chemotherapy and the risk of a SMN, and investigated the effect of chemo-radiotherapy on the risk of SMN. A case-control study nested in a European cohort of 4,581 patients treated for a solid cancer during childhood was conducted. One hundred and fifty three cases with a SMN and 442 controls were matched according to sex, age at first cancer, calendar year, type of first cancer and follow-up. The local radiation dose was estimated at the site of the SMN, for each case and at the same site, for the matched controls. The local dose of radiation significantly increased the risk of a SMN. The best model was linear with an excess relative risk per Gray equal to 0.13 (95% CI, 0.06; 0.26). Any chemotherapy significantly increased the risk of a SMN, odd ratio(adjusted) (OR(adjusted)) = 2.4 (95% confidence interval (95% CI), 1.4-4.1), but no dose-effect relationship was observed between any drug category and the risk of a SMN. Patients who had received concomitant chemo-radiotherapy were significantly more at risk of developing a SMN than patients who had been treated with sequential chemo-radiotherapy, even after adjustment for the local dose of radiation and the 6 most frequently administered drugs, OR(adjusted) = 2.3 (95%CI, 1.1-4.8). Radiation was found to be the foremost treatment-related risk factor for the occurrence of a SMN. Compared to sequential treatment, concomitant chemo-radiotherapy may lead to a higher risk of a SMN.
Mesh Headings (Keywords): Adolescent, Adult, Antineoplastic Agents, Case-Control Studies, Child, Child, Preschool, Combined Modality Therapy, Dose-Response Relationship, Drug, Dose-Response Relationship, Radiation, Female, Follow-Up Studies, Humans, Male, Middle Aged, Neoplasms, Neoplasms, Radiation-Induced, Neoplasms, Second Primary, Radiotherapy, Radiotherapy Dosage, Risk Factors
Check for Full Text / PubMed Unique Identifier (PMID): 17013899
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.